TrialGene therapy2020

Investigation of the safety and feasibility of AAV1/SERCA2a gene transfer in patients with chronic heart failure supported with a left ventricular assist device - the SERCA-LVAD TRIAL.

A R Lyon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.